byMediaBoost

MindRank

Raised $52M, announced 13 July 2026.

Round

MindRank raised $52 million to advance its AI drug platform.

Amount
$52M
Announced
13 July 2026
Use of funds
Scaling its drug discovery platform and advancing its clinical and preclinical pipeline, including MDR-001.
Checked
Amount and date checked against the press source

Company

Develops artificial intelligence platform for drug discovery and development.

Based in
Hangzhou, China
Sector
AI
Website
mindrank.ai ↗

Founder

  • Zhangming Niufounder and CEO

Sources and links

Source
MindRank raises $52m to advance AI drug platform - BioXconomy news.google.com
Website
mindrank.ai ↗
MediaBoost

Just raised?

MediaBoost gets your round in front of the press, future hires and your next investors.

Announce your round with MediaBoost